BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20380601)

  • 1. Percutaneous radiofrequency ablation for lung tumors beneath the rib under CT fluoroscopic guidance with gantry tilt.
    Suzuki T; Yamagami T; Tanaka O; Yoshimatsu R; Miura H; Nishimura T
    Acta Radiol; 2010 May; 51(4):389-95. PubMed ID: 20380601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous needle biopsy for small lung nodules beneath the rib under CT scan fluoroscopic guidance with gantry tilt.
    Yamagami T; Kato T; Iida S; Hirota T; Nishimura T
    Chest; 2004 Sep; 126(3):744-7. PubMed ID: 15364751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transosseous Route for CT Fluoroscopy-Guided Radiofrequency Ablation of Lung Tumors.
    Iguchi T; Hiraki T; Ishii H; Gobara H; Fujiwara H; Matsui Y; Kanazawa S
    J Vasc Interv Radiol; 2015 Nov; 26(11):1694-8. PubMed ID: 26432461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.
    Suh RD; Wallace AB; Sheehan RE; Heinze SB; Goldin JG
    Radiology; 2003 Dec; 229(3):821-9. PubMed ID: 14657317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
    de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
    Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
    VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
    AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance.
    Hess A; Palussière J; Goyers JF; Guth A; Aupérin A; de Baère T
    Radiology; 2011 Feb; 258(2):635-42. PubMed ID: 21273525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transpulmonary radiofrequency ablation for hepatocellular carcinoma under real-time computed tomography-fluoroscopic guidance.
    Kato T; Yamagami T; Hirota T; Matsumoto T; Yoshimatsu R; Nishimura T
    Hepatogastroenterology; 2008; 55(85):1450-3. PubMed ID: 18795709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
    Gadaleta CD; Solbiati L; Mattioli V; Rubini G; Fazio V; Goffredo V; Vinciarelli G; Gadaleta-Caldarola G; Canniello E; Armenise F; D'Aluisio L; Gaudiano A; Ranieri G; Goldberg SN
    Radiology; 2013 May; 267(2):627-37. PubMed ID: 23249572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience.
    Yasui K; Kanazawa S; Sano Y; Fujiwara T; Kagawa S; Mimura H; Dendo S; Mukai T; Fujiwara H; Iguchi T; Hyodo T; Shimizu N; Tanaka N; Hiraki Y
    Radiology; 2004 Jun; 231(3):850-7. PubMed ID: 15105453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.
    Akeboshi M; Yamakado K; Nakatsuka A; Hataji O; Taguchi O; Takao M; Takeda K
    J Vasc Interv Radiol; 2004 May; 15(5):463-70. PubMed ID: 15126656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.
    Akhan O; Güler E; Akıncı D; Çiftçi T; Köse IÇ
    Diagn Interv Radiol; 2016; 22(1):65-71. PubMed ID: 26611111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
    Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors.
    Yoshimatsu R; Yamagami T; Terayama K; Matsumoto T; Miura H; Nishimura T
    Chest; 2009 Apr; 135(4):1002-1009. PubMed ID: 19017870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
    J Vasc Interv Radiol; 2006 Oct; 17(10):1625-9. PubMed ID: 17057004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months.
    Arima K; Yamakado K; Suzuki R; Matsuura H; Nakatsuka A; Takeda K; Sugimura Y
    Urology; 2007 Sep; 70(3):407-11. PubMed ID: 17905083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness.
    Iguchi T; Hiraki T; Gobara H; Mimura H; Fujiwara H; Tajiri N; Sakurai J; Yasui K; Date H; Kanazawa S
    J Vasc Interv Radiol; 2007 Jun; 18(6):733-40. PubMed ID: 17538135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.